Direct-to-consumer virtual care company his and her health reported fourth quarter total revenue of $246.6 million compared to 2022 total revenue of $167.2 million, and 2023 year-over-year total revenue of $167.2 million. It reported $872 million compared to $26.9 million.
The San Francisco-based company reported fourth-quarter net income of $1.2 million, compared to a net loss of $10.9 million in the fourth quarter of 2022.
Net loss for 2023 was $23.5 million, compared to $65.7 million a year earlier.
The company's gross margin increased from 79% in Q4 2022 to 83% in Q4 2023, similar to annual gross profit growth in 2023 of 82% from 78% in 2022. It is.
Adjusted EBITDA was $20.6 million in the fourth quarter of 2023 compared to $3.9 million in the fourth quarter of 2022, resulting in a loss of $49.5 million for the year and a loss of $15.8 million in 2022.
The company reported that the number of subscribers reached 1.5 million in the fourth quarter of 2023, an increase of 48% year-on-year.
„Our strong performance in 2023 reflects the strength of the Hims & Hers brand and strong execution across the organization,“ co-founder and CEO Andrew Dadham said in a statement. I'm emphasizing that.“
“In 2024, our continued focus on building personalized, accessible treatments in each of our core specialties will drive us to exceed $1 billion in sales and reach our first full year We believe this approach will meaningfully break down the barriers to maintaining the status quo.'' will be made available to subscribers. ”
bigger trends
him and her completed the merger In 2021, it partnered with special purpose acquisition company (SPAC) Oaktree Acquisition and began trading on the New York Stock Exchange at $9.80 per share.
Since then, the company has stock price It reached a high of $23.99 in 2021 and is currently hovering around $14.62 per share.
in 3rd quarter of last yearThe company reported revenue of $226.7 million, up 57% year-over-year, compared to $144.8 million in the same period in 2022, compared to $226.7 million in revenue for the same period in 2022, compared to $226.7 million in revenue for the same period in 2022. announced the launch of an AI-enabled product in beta testing called . Points generated from the company's customer database help patients suffering from anxiety and depression identify the right treatment depending on their individual needs.
In November, Hims & Hers Chief Medical Officer Dr. Patrick Carroll said: Mobi Health News for exclusive interview Discuss the company's EMR and MedMatch.
“What we do is we have millions of data points coming from completely vertical systems, so we have insights into patient demographics, past medical history, medications. ” Carol said. „So when you have these millions of data points, you can imagine that it's like a treasure trove for people in the machine learning and AI field.“